Neurology and Neurosurgery - Global Neurology Academy

Episodes 33-48 of 351

Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Global Neurology Academy
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
- Lauren Schaff, MD
Climate Change in the Clinic: Examining Neurological Impacts
Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiers
Climate Change in the Clinic: Examining Neurological Impacts
- Beth Ann Malow, MD, MS
mIDH Gliomas Explained: Characteristics and Management Strategies
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
- Jennie Taylor, MD
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- Jennie Taylor, MD
Optimizing TK2d Care Through a Multidisciplinary Approach
Optimizing TK2d Care Through a Multidisciplinary Approach
NeuroFrontiers
Optimizing TK2d Care Through a Multidisciplinary Approach
- Charles Turck, PharmD, BCPS, BCCCP
- Kaitlin Batley, MD
- Esra Caylan, MD
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Global Neurology Academy
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
- Hans Katzberg, MD
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Global Neurology Academy
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
- Sami Khella, MD
Understanding CIDP: A Roadmap to Diagnosis
Understanding CIDP: A Roadmap to Diagnosis
Global Neurology Academy
Understanding CIDP: A Roadmap to Diagnosis
- Sami Khella, MD
Genetics in Schizophrenia Management: Emerging Technological Strategies
Genetics in Schizophrenia Management: Emerging Technological Strategies
Psychiatry and Mental Health
Genetics in Schizophrenia Management: Emerging Technological Strategies
- Aaron Besterman, MD
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiers
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
- Craig M. McDonald, MD
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiers
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
- Craig M. McDonald, MD

3/8